Starry Pharmaceutical Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
1,905
- Stock Symbol
-
603520
- Investments
-
7
- Share Price
-
$1.16
- (As of Monday Closing)
Starry Pharmaceutical General Information
Description
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Contact Information
Website
www.starrypharm.comCorporate Office
- No. 1 Starry Road of Modern Industrial Centralization Zone
- Xianju County
- Taizhou, Zhejiang 317306
- China
Corporate Office
- No. 1 Starry Road of Modern Industrial Centralization Zone
- Xianju County
- Taizhou, Zhejiang 317306
- China
Starry Pharmaceutical Stock Performance
As of 16-Nov-2026, Starry Pharmaceutical’s stock price is $1.16. Its current market cap is $509M with 438M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.16 | $1.16 | $1.14 - $2.11 | $509M | 438M | 6.52M |
Starry Pharmaceutical Financials Summary
As of 30-Sep-2026, Starry Pharmaceutical has a trailing 12-month revenue of $379M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 955,725 | 917,821 | 782,252 | 1,018,275 |
| Revenue | 378,521 | 340,100 | 327,536 | 310,392 |
| EBITDA | 15,022 | 45,011 | 35,225 | 45,225 |
| Net Income | 3,857 | 1,422 | (6,843) | 6,252 |
| Total Assets | 870,819 | 879,734 | 828,155 | 778,210 |
| Total Debt | 415,207 | 412,539 | 351,275 | 431,174 |
Starry Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Starry Pharmaceutical Signals
Starry Pharmaceutical Investments & Acquisitions (7)
Starry Pharmaceutical’s most recent deal was a Secondary Transaction - Private with Ruishi Pharmaceutical for . The deal was made on 07-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ruishi Pharmaceutical | 07-Sep-2026 | Secondary Transaction - Private | Other Healthcare Services | ||
| DDSome Lab | 06-Jul-2023 | Later Stage VC | Drug Delivery | ||
| Eyougene | 17-Feb-2021 | Corporate | Drug Discovery | ||
| DDSome Lab | 01-Jan-2021 | Later Stage VC | Drug Delivery | ||
| Haishen Pharmaceutical | 01-Oct-2019 | Secondary Transaction - Private | Pharmaceuticals |
Starry Pharmaceutical ESG
Risk Overview
Risk Rating
Updated June, 30, 2023
35.26 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,201
Rank
Percentile
Pharmaceuticals
Industry
of 863
Rank
Percentile
Pharmaceuticals
Subindustry
of 430
Rank
Percentile
Starry Pharmaceutical Exits (2)
Starry Pharmaceutical’s most recent exit was on 06-Jul-2023 from DDSome Lab. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| DDSome Lab | 06-Jul-2023 | Completed |
|
||
| DDSome Lab | 01-Jan-2021 | Later Stage VC | Completed |
|
Starry Pharmaceutical Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| iMAX Diagnostic Imaging | Cork, Ireland | 2011 | |
| Haishen Pharmaceutical | Taizhou, China | 2003 |
Starry Pharmaceutical FAQs
-
When was Starry Pharmaceutical founded?
Starry Pharmaceutical was founded in 1997.
-
Where is Starry Pharmaceutical headquartered?
Starry Pharmaceutical is headquartered in Taizhou, China.
-
What is the size of Starry Pharmaceutical?
Starry Pharmaceutical has 1,905 total employees.
-
What industry is Starry Pharmaceutical in?
Starry Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Starry Pharmaceutical a private or public company?
Starry Pharmaceutical is a Public company.
-
What is Starry Pharmaceutical’s stock symbol?
The ticker symbol for Starry Pharmaceutical is 603520.
-
What is the current stock price of Starry Pharmaceutical?
As of 16-Nov-2026 the stock price of Starry Pharmaceutical is $1.16.
-
What is the current market cap of Starry Pharmaceutical?
The current market capitalization of Starry Pharmaceutical is $509M.
-
What is Starry Pharmaceutical’s current revenue?
The trailing twelve month revenue for Starry Pharmaceutical is $379M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process